Salicylic acid

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the removal of warts, including plantar warts, flat warts, common warts, as well as corns and calluses. Plantar warts are specifically characterized by their location on the bottom of the foot, tenderness upon pressure, and disruption of the normal footprint pattern.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The affected area should be washed thoroughly prior to treatment. It is recommended to soak the wart in warm water for approximately 5 minutes to facilitate the process. After soaking, the area must be dried completely.

Using an applicator, such as a cotton swab, a layer of ointment should be applied to sufficiently cover each wart. It is important to allow the ointment to fully absorb into the skin. If necessary, the treated area may be covered with a bandage to protect it.

This procedure should be repeated once or twice daily as needed, continuing until the wart is removed, for a maximum duration of 12 weeks.

Contraindications

Use of this product is contraindicated in the following situations:

Application on damaged skin, including cuts, abrasions, eczema, or sunburn, is prohibited due to the potential for irritation and adverse reactions. Additionally, individuals with known allergies to any of the product's ingredients should refrain from use to avoid allergic reactions. The product is also contraindicated in pregnant or breastfeeding individuals, as safety in these populations has not been established.

Warnings and Precautions

The liquid formulation is prone to volatilization and crystallization; therefore, it is imperative to securely tighten the cap after each use to maintain its integrity. Prolonged exposure to air should be avoided to ensure optimal efficacy.

This product is intended for external use only. It must not come into contact with the eyes or be ingested. Pediatric use should be supervised by an adult to prevent accidental ingestion or misuse.

In the event of accidental ingestion, immediate medical assistance should be sought. Contact a Poison Control Center or seek emergency medical help without delay.

Patients are advised to discontinue use and consult a healthcare professional if they experience any adverse reactions or if there is a suspicion of a more serious skin condition. Regular monitoring and assessment by a healthcare provider are recommended to ensure safe and effective use of this product.

Side Effects

Patients using this product should be aware of several important warnings and potential adverse reactions. The liquid formulation is prone to volatilization and crystallization; therefore, it is essential to tighten the cap securely after each use to maintain its integrity. Long-term exposure to air should be avoided to prevent degradation of the product.

This product is intended for external use only. Patients must take care to avoid contact with the eyes and should not swallow the liquid. It is recommended that children use this product under the supervision of adults to ensure safety.

In the event of adverse reactions, patients are advised to consult a healthcare professional, as they may be experiencing a more serious skin condition that requires medical attention.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Wart Remover. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should use this medication under the supervision of adults to ensure safe administration and monitoring. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients and those who are breastfeeding should not use this medication. The potential risks associated with the use of this drug during pregnancy have not been established, and there is insufficient data to determine its safety profile in this population. Healthcare professionals are advised to consider alternative treatments for women who are pregnant or breastfeeding to avoid any potential adverse effects on fetal outcomes or nursing infants.

Lactation

Lactating mothers are advised against the use of this medication. There is no available data on the excretion of the drug in human breast milk or its effects on breastfed infants. Therefore, due to the lack of safety information, breastfeeding is not recommended while using this medication.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

There is no information available regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise caution and consider the overall clinical context when prescribing this medication to patients with liver problems, as the absence of specific guidance necessitates careful evaluation of potential risks and benefits.

Overdosage

There is currently no specific information available regarding overdosage for this medication. Healthcare professionals are advised to monitor patients closely for any signs of adverse effects or symptoms that may arise from excessive dosing.

In the event of suspected overdosage, it is recommended that healthcare providers initiate supportive care and symptomatic treatment as necessary. Patients should be evaluated for potential complications, and appropriate interventions should be implemented based on clinical judgment.

For further guidance, healthcare professionals may refer to established protocols for managing drug overdosage or consult a poison control center.

Nonclinical Toxicology

The use of this product is contraindicated in pregnant or breastfeeding individuals due to potential teratogenic effects. No non-teratogenic effects have been identified in the available data. There are no additional findings related to nonclinical toxicology or animal pharmacology and toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the product out of reach of children to prevent accidental ingestion. Instruct patients that if the product is swallowed, they should seek medical help or contact a Poison Control Center immediately.

Patients should be informed not to use the product on damaged skin, including areas with cuts, abrasions, eczema, or sunburn, as this may exacerbate their condition. Additionally, it is crucial to advise patients against using the product if they have a known allergy to any of its ingredients.

Healthcare providers should also counsel patients that the product is not recommended for use during pregnancy or while breastfeeding. Furthermore, patients should be encouraged to consult their doctor if they suspect they may have a more serious skin condition, as this may require a different treatment approach.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at a temperature range of 68°F to 77°F (20°C to 25°C) to maintain its integrity and efficacy. Care should be taken to protect the product from excessive heat, specifically temperatures exceeding 104°F (40°C), to prevent degradation. Proper storage conditions are crucial for ensuring the product remains effective throughout its shelf life.

Additional Clinical Information

The medication is administered topically, with the recommended frequency being once or twice daily as needed until the wart is removed, for a maximum duration of 12 weeks. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Wart Remover, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)